This site is intended for Healthcare Professionals only.

ABPI elects Pfizer’s Susan Rienow as vice president

Date:

Share post:

The Association of the British Pharmaceutical Industry (ABPI) has appointed Susan Rienow, country president of Pfizer, as its vice president.

As vice president, she will support the president, Pinder Sahota, general manager and corporate vice president of Novo Nordisk UK, in delivering his priorities. These are improving access to medicines, delivering economic growth and helping to find solutions to big societal challenges such as climate change, AMR, and inequalities,” said ABPI in a statement.

At Pfizer, Susan leads the organisation to bring the power of innovation, data and technology together to transform healthcare and improve outcomes for patients. She previously led Pfizer UK’s vaccines business unit during the Covid-19 pandemic.

Commenting on her appointment, Susan said: “The pharmaceutical industry can play a crucial role in generating the economic growth the UK desperately needs at this point, as well as helping the NHS to recover from the pandemic.

“I look forward to working with the president to make sure that lessons from the pandemic are learned and innovative medicines and vaccines reach the people who need them.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

RPS releases general election manifesto: Key asks revealed

It urges the next government to review prescription charges in England and strengthen the UK’s medicines supply...

CCA urges urgent action on shortage of designated prescribing practitioners

It has repeatedly warned NHS England of the likely consequences arising from the lack of designated prescribing practitioners  The...

First pharmacist to lead training initiatives for critical care professionals: Reena Mehta

Spearheading the educational efforts and training initiatives for the Intensive Care Society, Reena Mehta ,the first pharmacist, to...

#Fight4Pharmacies: IPA warns ‘there simply won’t be enough community pharmacies left to deliver PFS”

'95 per cent community pharmacies rely on the NHS to sustain,' according to Fight4Pharmacies petition "If the Government does...